Qualitative analysis of CD8+ T cells
| . | Patient 3 . | Patient 4 . |
|---|---|---|
| Activated CD8+T cells during T-cell expansion | ||
| CD8+CD38+DR+ | 54.8% (day +8) | 43.2% (day +8) |
| Activated CD8+T cells after trough of T-cell expansion | ||
| CD8+CD38+DR+ | 7.4% (day +23) | 8.1% (day +20) |
| Activated CD8+T-cell/T-regulatory cell ratio during T-cell expansion | ||
| Activated CD8+ T-cell/T-regulatory cell ratio | 10.9 (day +8) | 4.2 (day +8) |
| Activated CD8+T-cell/T-regulatory cell ratio after trough of T-cell expansion | ||
| Activated CD8+ T-cell/T-regulatory cell ratio | 0.42 (day +23) | 0.69 (day +20) |
| Cytotoxic degranulation assay during T-cell expansion | ||
| CD107a, patient/control | 9.4/2.3 (day +8) | 54.8/5.8 (day +8) |
| . | Patient 3 . | Patient 4 . |
|---|---|---|
| Activated CD8+T cells during T-cell expansion | ||
| CD8+CD38+DR+ | 54.8% (day +8) | 43.2% (day +8) |
| Activated CD8+T cells after trough of T-cell expansion | ||
| CD8+CD38+DR+ | 7.4% (day +23) | 8.1% (day +20) |
| Activated CD8+T-cell/T-regulatory cell ratio during T-cell expansion | ||
| Activated CD8+ T-cell/T-regulatory cell ratio | 10.9 (day +8) | 4.2 (day +8) |
| Activated CD8+T-cell/T-regulatory cell ratio after trough of T-cell expansion | ||
| Activated CD8+ T-cell/T-regulatory cell ratio | 0.42 (day +23) | 0.69 (day +20) |
| Cytotoxic degranulation assay during T-cell expansion | ||
| CD107a, patient/control | 9.4/2.3 (day +8) | 54.8/5.8 (day +8) |